Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations

NCCN Task Force Report: Evaluating the Clinical Utility of Tumor Markers in Oncology

(2017) Phillip G. Febbo et al.   Journal of the National Comprehensive Cancer Network

Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold

(2015) Karl Claxton et al.   HEALTH TECHNOLOGY ASSESSMENT

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing

(2014) Ranjit Manchanda et al.   JNCI-Journal of the National Cancer Institute

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Strategies to Identify the Lynch Syndrome Among Patients With Colorectal Cancer

(2013) Uri Ladabaum et al.   ANNALS OF INTERNAL MEDICINE

Economic analyses of genetic tests in personalized medicine: clinical utility first, then cost utility

(2013) Scott D. Grosse   GENETICS IN MEDICINE

The economic value of personalized medicine tests: what we know and what we need to know

(2013) Kathryn A Phillips et al.   GENETICS IN MEDICINE

Knowledge, attitudes and behavior of physicians regarding predictive genetic tests for breast and colorectal cancer

(2013) Carolina Marzuillo et al.   PREVENTIVE MEDICINE

Developing National Guidance on Genetic Testing for Breast Cancer Predisposition: The Role of Economic Evidence?

(2012) William Sullivan et al.   Genetic Testing and Molecular Biomarkers

Economic Evaluations Conducted for Assessment of Genetic Testing Technologies: A Systematic Review

(2012) Nazila Assasi et al.   Genetic Testing and Molecular Biomarkers

The Cost-Effectiveness of Environmental Approaches to Disease Prevention

(2012) Dave A. Chokshi et al.   NEW ENGLAND JOURNAL OF MEDICINE

A review of economic evaluations of genetic testing services and interventions (2004–2009)

(2011) Sandjar Djalalov et al.   GENETICS IN MEDICINE

Awareness and Utilization of BRCA1/2 Testing Among U.S. Primary Care Physicians

(2010) Cecelia A. Bellcross et al.   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer

(2010) Mercy Mvundura et al.   GENETICS IN MEDICINE

Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidence

(2010) Muin J Khoury et al.   GENETICS IN MEDICINE

Expanding the Criteria forBRCAMutation Testing in Breast Cancer Survivors

(2010) Janice S. Kwon et al.   JOURNAL OF CLINICAL ONCOLOGY

Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: A call for dialogue

(2009) Wendy S Rubinstein et al.   GENETICS IN MEDICINE

Systematic reviews of economic evaluations: utility or futility?

(2009) Rob Anderson   HEALTH ECONOMICS

Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations

(2009) Janice S. Kwon et al.   JOURNAL OF CLINICAL ONCOLOGY

Translational Research in Cancer Genetics: The Road Less Traveled

(2009) S.D. Schully et al.   Public Health Genomics

Does Preventive Care Save Money? Health Economics and the Presidential Candidates

(2008) Joshua T. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cost-Effectiveness of Testing for Breast Cancer Susceptibility Genes

(2008) Margaret L. Holland et al.   VALUE IN HEALTH